An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts

NCT00000709 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

AIDS Dementia Complex
HIV Infections

Interventions

DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)